评估ChatGPT-4o和OpenEvidence对结构性心脏病的支持：来自三尖瓣治疗的见解。
Evaluating ChatGPT-4o and OpenEvidence for Structural Heart Disease Support: Insights From Tricuspid Valve Therapies.
作者信息
Hajj Joseph, Mdaihly Mohamad, Kassab Joseph, Miyasaka Rhonda, Harb Serge C
机构信息
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.
出版信息
Struct Heart. 2025 Jul 5;9(9):100696. doi: 10.1016/j.shj.2025.100696. eCollection 2025 Sep.
•Evaluated ChatGPT-4o and OpenEvidence for structural heart disease decision support.•Among the first to assess the use of artificial intelligence amid rising adoption of TriClip and EVOQUE for transcatheter tricuspid valve interventions.•ChatGPT-4o delivered more accurate responses and proved more clinically reliable.•Neither platform replaces clinical judgment; ChatGPT-4o excels in fast-paced settings.
•评估ChatGPT-4o和OpenEvidence在结构性心脏病决策支持方面的表现。
•在经导管三尖瓣介入治疗中，随着TriClip和EVOQUE的使用日益增多，率先评估人工智能的应用情况。
•ChatGPT-4o给出了更准确的回答，且在临床方面更可靠。
•两个平台都不能取代临床判断；ChatGPT-4o在快节奏环境中表现出色。
Zotero 插件